How is the Actuate Therapeutics Inc. today?

The Actuate Therapeutics Inc. today is trading in the down by -7.93% at 9.75.

What is Actuate Therapeutics Inc. Annual Net Profit?

Actuate Therapeutics Inc. Annual Net Profit fell 10.27% in the last year to $27.29 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Actuate Therapeutics Inc. Price to Earning Ratio?

Actuate Therapeutics Inc. Price to Earning Ratio is -7.56, which is negative.

What is Actuate Therapeutics Inc. Stock Price?

Actuate Therapeutics Inc. Stock Price fell 5.61% underperformed its sector by 8.83% in the past week.

What is Actuate Therapeutics Inc. Quarterly Net profit?

Actuate Therapeutics Inc. Quarterly Net profit rose 23.86% YoY to $6.32 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Actuate Therapeutics Inc. Mutual Fund Holding?

Actuate Therapeutics Inc. Mutual Fund Holding increased by 1.25% in the last quarter to 1.59.

What is Actuate Therapeutics Inc. Interest Coverage Ratio?

Actuate Therapeutics Inc. Interest Coverage Ratio is -1456.78, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Actuate Therapeutics Inc. Institutional Holding?

Actuate Therapeutics Inc. Institutional Holding increased by 0.86% in the last quarter to 52.65.

Actuate Therapeutics Inc. XNAS: ACTU

Actuate Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Actuate Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Actuate Therapeutics Inc.
Rating: 1.27900
Author: Trendlyne DVM scores

about

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglu...

9.75 -0.84 (-7.93%)

New 52W High in past week

88,578 XNAS Volume

XNAS 03 Jun, 2025 4:02 PM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Neutral

51.2 / 100

No estimates available

Actuate Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Actuate Therapeutics Inc. FAQ

How is Actuate Therapeutics Inc. today?

Actuate Therapeutics Inc. today is trading in the red, and is down by -7.93% at 9.75.

How has Actuate Therapeutics Inc. performed historically?

Actuate Therapeutics Inc. is currently trading down -7.93% on an intraday basis. In the past week the stock fell -5.61%. stock has been up 34.67% in the past quarter and fell None% in the past year. You can view this in the overview section.